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Abstract
Problem: Preterm birth is commonly preceded by preterm labor, a syndrome that 
is causally linked to both intra‐amniotic infection and intra‐amniotic inflammation. 
However, the stereotypical cellular immune responses in these two clinical condi‐
tions are poorly understood.
Method of study: Amniotic fluid samples (n = 26) were collected from women di‐
agnosed with preterm labor and intra‐amniotic infection (amniotic fluid IL‐6 con‐
centrations	 ≥2.6	 ng/mL	 and	 culturable	 microorganisms,	 n	 =	 10)	 or	 intra‐amniotic	
inflammation	(amniotic	fluid	IL‐6	concentrations	≥2.6	ng/mL	without	culturable	mi‐
croorganisms, n = 16). Flow cytometry was performed to evaluate the phenotype and 
number of amniotic fluid leukocytes. Amniotic fluid concentrations of classical pro‐
inflammatory cytokines, type 1 and type 2 cytokines, and T‐cell chemokines were 
determined using immunoassays.
Results: Women with spontaneous preterm labor and intra‐amniotic infection had 
(a) a greater number of total leukocytes, including neutrophils and monocytes/mac‐
rophages, in amniotic fluid; (b) a higher number of total T cells and CD4+ T cells, but 
not CD8+ T cells or B cells, in amniotic fluid; and (c) increased amniotic fluid concen‐
trations of IL‐6, IL‐1β, and IL‐10, compared to those with intra‐amniotic inflamma‐
tion. However, no differences in amniotic fluid concentrations of T‐cell cytokines and 
chemokines were observed between these two clinical conditions.
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1  | INTRODUC TION
Preterm birth remains one of the most common obstetrical syndromes 
today and is a primary cause of perinatal morbidity and mortality world‐
wide.1‐5 On average, two‐thirds of all preterm births are preceded by 
spontaneous preterm labor,6 a syndrome of multiple etiologies.7 Of all 
the proposed causes of preterm labor, intra‐amniotic inflammation/
infection has been causally linked to preterm birth.8‐17 Intra‐amni‐
otic inflammation can result from microbial invasion of the amniotic 
cavity, which is referred to as intra‐amniotic infection.9,10,12,18‐29 Yet, 
inflammation in the amniotic cavity can also occur in the absence of 
culturable microorganisms, which is simply known as intra‐amniotic 
inflammation.16,27,30 Recently, we showed using molecular microbi‐
ological techniques that a subset of patients with preterm labor and 
intra‐amniotic inflammation do not have detectable bacteria in the 
amniotic cavity, which we termed sterile intra‐amniotic inflamma‐
tion.31‐34 This condition is associated with elevated concentrations of 
endogenous danger signals, or alarmins (molecules released upon cel‐
lular stress or damage35‐37), in amniotic fluid;38‐43 although of interest, 
it is not yet a clinical diagnosis as the use of molecular microbiological 
techniques is not common practice in obstetrics. Therefore, patients 
with preterm labor are either diagnosed with intra‐amniotic infection 
or intra‐amniotic inflammation. Although both clinical conditions are 
associated with preterm labor and adverse neonatal outcomes,32,44 
their management is different (intra‐amniotic infection is treated with 
antibiotics45), and only intra‐amniotic infection is linked to maternal 
morbidity and mortality.46 Therefore, elucidating the stereotypical im‐
mune responses in intra‐amniotic infection and intra‐amniotic inflam‐
mation is essential for understanding these clinical conditions.
Flow cytometry has emerged as a cutting‐edge technique for the 
evaluation of immune cells in small volumes of biological fluids such 
as cerebrospinal fluid,47,48 urine,49‐51 ascitic fluid,52 and sputum53 
in the clinical setting. Indeed, flow cytometry has been utilized to 
identify	specific	immune	cell	types,	as	well	as	their	expressed	medi‐
ators, in amniotic fluid of women with intra‐amniotic inflammation/
infection and clinical chorioamnionitis at term.54,55 This technique 
also allowed for the identification of the newly described innate 
lymphoid cells in the amniotic cavity of women during the second 
trimester.55,56 Herein, we utilized flow cytometry to characterize 
the cellular immune responses in the amniotic cavity of women 
diagnosed with preterm labor and intra‐amniotic infection or intra‐
amniotic inflammation.
2  | MATERIAL S AND METHODS
2.1 | Study population and characteristics
This cross‐sectional study included patients who underwent 
transabdominal amniocentesis due to clinical indications. The col‐
lection of samples was approved by the Institutional Review Boards 
of the Detroit Medical Center (Detroit, MI, USA), Wayne State 
University, and the Perinatology Research Branch, an intramural 
program of the Eunice Kennedy Shriver National Institutes of Health, 
National Institutes of Health,US Department of Health and Human 
Services (NICHD/NIH/DHHS). All women provided written in‐
formed consent prior to the collection of amniotic fluid. This study 
included 26 amniotic fluid samples (collected from 2013 to 2016) 
from women classified into the following groups: (a) women with 
spontaneous preterm labor who delivered preterm with intra‐amni‐
otic inflammation (n = 16) and (b) women with spontaneous preterm 
labor who delivered preterm with intra‐amniotic infection (n = 10) 
(see diagnostic criteria below). For all patients who delivered pre‐
term, the time between the collection of the amniotic fluid sample 
and	delivery	was	≤7	days.	Demographic	and	clinical	characteristics	
of the study population are shown in Table 1.
2.2 | Clinical definitions
Gestational age was determined by the date of the last menstrual pe‐
riod	and	confirmed	by	ultrasound	examination.	The	gestational	age	de‐
rived from sonographic fetal biometry was used if the estimation was 
inconsistent with menstrual dating. Spontaneous preterm labor was 
diagnosed by the presence of regular uterine contractions (at least two 
contractions every 10 minutes) associated with cervical changes in pa‐
tients <37 weeks of gestation. Microbial invasion of the amniotic cavity 
(MIAC) was defined as a positive amniotic fluid culture, including geni‐
tal mycoplasmas.9,10,22,57,58 Intra‐amniotic inflammation was defined 
as	an	amniotic	fluid	IL‐6	concentration	≥2.6	ng/mL	in	the	absence	of	
culturable bacteria. 27,59‐64 Intra‐amniotic infection was defined as the 
presence of MIAC together with intra‐amniotic inflammation.31‐33,65‐74
Conclusion: The cellular immune responses observed in women with preterm labor 
and intra‐amniotic infection are more severe than in those with intra‐amniotic in‐
flammation, and neutrophils, monocytes/macrophages, and CD4+ T cells are the main 
immune cells responding to microorganisms that invade the amniotic cavity. These 
findings provide insights into the intra‐amniotic immune mechanisms underlying the 
human syndrome of preterm labor.
K E Y W O R D S
chorioamnionitis, fetal inflammatory response syndrome, funisitis, microbial invasion of the 
amniotic cavity, placental inflammation, pregnancy
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2.3 | Placental histopathological examination
Placentas	 were	 examined	 histologically	 by	 perinatal	 pathologists	
blinded to clinical diagnoses and obstetrical outcomes according to 
standardized Perinatology Research Branch protocols.75,76 Briefly, 
three	to	nine	sections	of	the	placenta	were	examined,	and	at	 least	
one full‐thickness section was taken from the center of the placenta; 
others were taken randomly from the placental disk. Acute inflam‐
matory lesions of the placenta (maternal inflammatory response and 
fetal inflammatory response) were diagnosed according to estab‐
lished criteria, including staging and grading.75,77 The proportions 
of patients whose placentas presented acute maternal and/or fetal 
inflammatory responses are displayed in Table 1.
2.4 | Amniotic fluid sample collection
Amniotic fluid samples were obtained by transabdominal amnio‐
centesis under antiseptic conditions and monitored by ultrasound 
in order to detect intra‐amniotic inflammation and/or infection 
in patients with preterm labor. Samples of amniotic fluid were 
transported to the laboratory in a sterile, capped syringe and immu‐
nophenotyping was performed immediately. The rest of the sample 
was centrifuged at 1300 g for 10 minutes at 4°C, and the super‐
natant	was	 stored	at	−80°C	until	 use.	Also,	 an	aliquot	of	 amniotic	
fluid was transported to the clinical laboratory for culture of aero‐
bic/anaerobic bacteria and genital mycoplasmas. The clinical tests 
also included the determination of an amniotic fluid white blood cell 
count,78	a	Gram	stain	examination,79 a glucose concentration,80 and 
an IL‐6 concentration.27
2.5 | Determination of IL‐6 in amniotic fluid
Amniotic fluid concentrations of IL‐6 were determined by using a 
sensitive and specific enzyme immunoassay obtained from R&D 
Systems (Minneapolis, MN, USA). The IL‐6 concentrations were de‐
termined by interpolation from the standard curve. The inter‐ and 
intra‐assay coefficients of variation for IL‐6 were 8.7% and 4.6%, 
respectively. The detection limit of the IL‐6 assay was 0.09 pg/mL. 
The IL‐6 concentrations in amniotic fluid were determined for clini‐
cal purposes.
TA B L E  1   Clinical and demographic characteristics of women who underwent spontaneous preterm labor
 
Preterm labor and birth with 
intra‐amniotic infection (n = 10)
Preterm labor and birth with  
intra‐amniotic inflammation (n = 16) P‐value
Maternal age (y; median [IQR])a 27.5	(22.8‐35.8) 25.5	(22‐28.3) .3
Body	mass	index	(kg/m2; median [IQR])a 28.3	(27‐36.5)d 26.3 (24.2‐30.7) .1
Primiparityb 0% (0/10) 12.5%	(2/16) .5
Raceb 1
African American 80% (8/10) 81.3% (13/16)
Caucasian 20% (2/10) 12.5%	(2/16)
Other 0% (0/10) 6.3% (1/16)
Gestational age at amniocentesis (wk; median [IQR])a 25.9	(22.5‐29.8) 27 (22.9‐31.2) .4
IL‐6 (ng/mL; median [IQR])a 128.7 (78‐186.2) 47.8 (16.7‐122.9) .04
White blood cell count, cells/mm3,a 307	(89‐1254.5) 2 (0‐11.8) .003
Amniotic fluid glucose, mg/dLa 3.5	(1‐9.8) 12.5	(6‐26) .053
Gestational age at delivery (wk; median [IQR])a 25.9	(23‐30) 27.6 (23.4‐31.3) .4
Cesarean sectionb 0% (0/10) 31.3%	(5/16) .1
Birthweight (g)a 935	(533.3‐1428.8) 1037.5	(697.5‐1778.8) .6
Acute maternal inflammatory response
Stage 1 (acute subchorionitis)b 0% (0/8)c 23.1% (3/13)d .2
Stage 2 ( acute chorioamnionitis)b 37.5%	(3/8)c 30.8% (4/13)d 1
Stage 3 (acute necrotizing chorioamnionitis)b 50%	(4/8)c 30.8% (4/13)d .6
Acute fetal inflammatory response
Stage 1 (acute phlebitis/chronic vasculitis)b 50%	(4/8)c 53.8%	(7/13)d 1
Stage 2 (acute arteritis)b 25%	(2/8)c 0% (0/13)d .1
Stage 3 (necrotizing funisitis)b 12.5%	(1/8)c 0% (0/13)d .3
Note: Data are given as median (interquartile range, IQR) and percentage (n/N).
aMann–Whitney U test. 
bFisher's	exact	test.	
cTwo missing data. 
dThree missing data. 
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2.6 | Immunophenotyping by flow cytometry
Amniotic	 fluid	 samples	 (0.5‐1	 mL)	 were	 centrifuged	 at	 300	 g for 
5	minutes	 at	 room	 temperature.	 The	 resulting	 amniotic	 fluid	 pellet	
was resuspended in 1 mL of 1X phosphate‐buffered saline (PBS) (Life 
Technologies, Grand Island, NY, USA) and stained with BD Horizon 
Fixable	Viability	Stain	510	dye	(BD	Biosciences,	San	Jose,	CA,	USA).	
Cells were washed in 1X PBS and incubated with 20 μL of human FcR 
blocking reagent (Miltenyi Biotec, San Diego, CA, USA) in 80 μL of 
stain	buffer	(BD	Biosciences)	for	10	minutes	at	4°C.	Next,	cells	were	
incubated	 with	 extracellular	 fluorochrome‐conjugated	 anti‐human	
monoclonal antibodies for 30 minutes at 4°C in the dark (Table S1). 
Stained	cells	were	then	washed	with	1X	PBS,	resuspended	in	0.5	mL	
of stain buffer, and acquired using the BD LSR II or LSRFortessa 
Flow Cytometer (BD Bioscience) and BD FACSDiva 6.0 software (BD 
Bioscience). The analysis was performed, and the figures were gen‐
erated	using	the	FlowJo	version	10	software	 (FlowJo,	Ashland,	OR,	
USA). The absolute number of cells was determined using CountBright 
absolute counting beads (Molecular Probes, Eugene, OR, USA).
2.7 | Amniotic fluid cytokine/chemokine 
concentrations
Amniotic	 fluid	 samples	 were	 assessed	 using	 the	 V‐PLEX	
Proinflammatory Panel 1 kit (Meso Scale Discovery, Rockville, MD, 
USA) to measure amniotic fluid concentrations of IFN‐γ, TNF‐α, 
IL‐1β, IL‐2, IL‐4, IL‐6, IL‐8, IL‐10, IL‐12p70, and IL‐13, according to the 
manufacturer's instructions. Plates were read using the SECTOR 
2400 Imager (Meso Scale Discovery). Standard curves were gener‐
ated, and the assay values of the samples were interpolated from the 
curves. The detection limits of the assays were 0.37 pg/mL (IFN‐γ), 
0.04 pg/mL (TNF‐α),	0.05	pg/mL	(IL‐1β), 0.09 pg/mL (IL‐2), 0.02 pg/
mL (IL‐4), 0.06 pg/mL (IL‐6), 0.07 pg/mL (IL‐8), 0.04 pg/mL (IL‐10), 
0.11 pg/mL (IL‐12p70), and 0.24 pg/mL (IL‐13). Inter‐assay and intra‐
assay	coefficients	of	variation	were	<10.5%.
Amniotic fluid concentrations of CXCL10 (Cat#DIP100, R&D 
Systems)	 and	 CXCL11	 (Cat#K151UWK‐1,	 Meso	 Scale	 Discovery)	
were determined using individual sensitive and specific immuno‐
assays, according to the manufacturers' instructions. The concen‐
trations of CXCL10 and CXCL11 were determined by interpolation 
from the standard curve. The detection limits of the assays were 
1.67	pg/mL	(CXCL10)	and	1.5	pg/mL	(CXCL11).	The	inter‐assay	and	
intra‐assay coefficients of variation were less than 9.8% for CXCL10 
and less than 16.8% for CXCL11.
2.8 | Statistical analysis
Statistical analyses were conducted using SPSS software ver‐
sion 19.0 (IBM Corporation, Armonk, NY, USA). For patient demo‐
graphics, the Mann‐Whitney U test was performed for continuous 
variables	and	Fisher's	exact	test	for	nominal	variables.	The	Mann–
Whitney U test was also performed when comparing cell numbers 
and cytokine/chemokine concentrations between the study groups. 
A P‐value	<.05	was	considered	statistically	significant.
3  | RESULTS
3.1 | Characteristics of the study population
The demographic and clinical characteristics of the study population 
are shown in Table 1. A total of 26 amniotic fluid samples were col‐
lected from women who underwent spontaneous preterm labor and 
birth either with intra‐amniotic infection (n = 10) or with intra‐amni‐
otic inflammation (n = 16). Amniotic fluid concentrations of IL‐6 and 
white blood cell counts were higher in women with preterm labor 
and intra‐amniotic infection compared to those with intra‐amniotic 
inflammation (Table 1). Glucose concentrations tended to be lower in 
women with intra‐amniotic infection compared to those with intra‐
amniotic inflammation (Table 1). Women with intra‐amniotic inflam‐
mation and those with intra‐amniotic infection presented acute 
maternal and fetal inflammatory responses in the placenta (Table 1). 
The following microorganisms were detected in women diagnosed 
with intra‐amniotic infection: Ureaplasma urealyticum, Mycoplasma 
hominis, Fusobacterium spp., Candida spp., Gardnerella vaginalis, 
Peptostreptococcus, Streptococcus serogroup C, and Enterococcus 
faecalis.
3.2 | Leukocyte populations in amniotic 
fluid of women with preterm labor and intra‐amniotic 
inflammation or intra‐amniotic infection
Figure 1A,C shows representative images of the flow cytom‐
etry gating strategy used to detect leukocytes in amniotic fluid 
from women with preterm labor and intra‐amniotic inflammation 
(Figure 1A) or intra‐amniotic infection (Figure 1C). Representative 
t‐SNE plots illustrate the amniotic fluid leukocyte populations 
found in the two study groups (Figure 1B,D). Notably, more women 
with preterm labor and intra‐amniotic infection (80%) displayed a 
high proportion of neutrophils and monocytes/macrophages in 
amniotic fluid compared to those with intra‐amniotic inflamma‐
tion	without	 detectable	microorganisms	 (50%;	 Figure	 1D	 vs	 1B).	
Indeed, the abundant neutrophils and monocytes/macrophages in 
amniotic fluid of women with intra‐amniotic infection masked the 
other immune cell types (eg, T cells and B cells) that are clearly 
identified in women with intra‐amniotic inflammation (Figure 1D 
vs 1B).
We then quantified the numbers of total leukocytes in amniotic 
fluid from the two study groups. Women with preterm labor and 
intra‐amniotic infection had greater total numbers of leukocytes 
in amniotic fluid compared to those with intra‐amniotic inflamma‐
tion	 (Figure	2A).	Quantification	of	 neutrophils	 (CD15+ leukocytes) 
and monocytes/macrophages (CD14+ leukocytes) in amniotic fluid 
showed that the numbers of these innate immune cells were greater 
in women with intra‐amniotic infection compared to those with 
intra‐amniotic inflammation (Figure 2B,C), mirroring the relative dif‐
ferences observed between the t‐SNE plots in Figure 1.
We previously demonstrated that adaptive immune cells (ie, T 
cells and B cells) are also present in amniotic fluid during normal 
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pregnancy.55 Therefore, we then determined whether the num‐
bers of such cells were altered in amniotic fluid from our two study 
groups. We found that the total T‐cell population (CD3+ leukocytes) 
and CD4+ T cells were significantly increased in women with preterm 
labor and intra‐amniotic infection compared to those with intra‐am‐
niotic inflammation (Figure 3A,B). The numbers of CD8+ T cells were 
also higher in women with preterm labor and intra‐amniotic infec‐
tion compared to those with intra‐amniotic inflammation, although 
this was not significant (Figure 3C). Lastly, we determined the num‐
bers of B cells (CD19+ leukocytes) and found no statistical differ‐
ences between the two study groups (Figure 3D).
Together, these results indicate that total leukocytes, as well as 
specific leukocyte subsets, namely neutrophils, monocytes/macro‐
phages, and CD4+ T cells, are increased in amniotic fluid of women 
with preterm labor and intra‐amniotic infection compared to those 
with intra‐amniotic inflammation.
3.3 | Cytokine and chemokine concentrations in 
amniotic fluid of women with preterm labor and intra‐
amniotic inflammation or intra‐amniotic infection
Next,	 we	 investigated	 whether	 the	 increased	 numbers	 of	 amniotic	
fluid leukocytes in women with preterm labor and intra‐amniotic in‐
fection were associated with an increase in cytokine concentrations. 
We found that the concentrations of the pro‐inflammatory cytokines 
IL‐6 and IL‐1β were both significantly elevated in amniotic fluid of 
women with preterm labor and intra‐amniotic infection compared 
to those with intra‐amniotic inflammation (Figure 4A,B). In contrast, 
F I G U R E  1   Leukocyte populations in amniotic fluid. Representative flow cytometry gating strategies and t‐distributed stochastic 
neighbor embedding (t‐SNE) plots showing leukocyte populations in amniotic fluid from women who underwent spontaneous preterm labor 
and birth with intra‐amniotic inflammation (A‐B) or with intra‐amniotic infection (C‐D). Immune cells were initially gated within the viability 
gate	and	CD45+	gate,	followed	by	lineage	gating	for	neutrophils	(CD45+	CD15+	cells),	monocytes/macrophages	(CD45+ CD14+ cells), T cells 
(CD45+ CD3+ cells), which were subsequently gated for CD4+	T	cells	(CD45+ CD3+ CD4+ cells) and CD8+	T	cells	(CD45+ CD3+ CD8+ cells), 
and	B	cells	(CD45+ CD19+ cells). Plots are representative of 10‐16 samples per group
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concentrations of IL‐8 and IL‐12p70 were not significantly different 
between women with preterm labor and intra‐amniotic infection and 
those with intra‐amniotic inflammation (Figure 4C,D).
As the numbers of amniotic fluid total T cells and CD4+ T 
cells were increased in women with intra‐amniotic infection, the 
concentrations of type 1 and type 2 cytokines, as well as T‐cell 
chemokines, were determined. The type 1 cytokines IL‐2, IFN‐γ, 
and TNF‐α were not significantly different between women with 
intra‐amniotic infection and those with intra‐amniotic inflamma‐
tion	 (Figure	5A‐C).	While	 IL‐4	and	 IL‐13	did	not	change,	 the	am‐
niotic fluid concentration of the type 2 cytokine IL‐10 tended 
to increase in women with intra‐amniotic infection compared to 
those	with	 intra‐amniotic	 inflammation	 (Figure	5D‐F).	No	differ‐
ences were observed in amniotic fluid concentrations of the T‐
cell chemokines CXCL10 and CXCL11 between the study groups 
(Figure	5G,H).
F I G U R E  2  Total	leukocytes	and	innate	immune	cells	in	amniotic	fluid.	Numbers	of	(A)	total	leukocytes	(CD45+ cells/mL), (B) neutrophils 
(CD15+ cells/mL), and (C) monocytes/macrophages (CD14+ cells/mL) in amniotic fluid from women who underwent spontaneous 
preterm labor and birth with intra‐amniotic inflammation or with intra‐amniotic infection. N = 10‐16 per group. Midlines = medians, 
boxes	=	interquartile	ranges,	and	whiskers	=	minimum/maximum	ranges
F I G U R E  3   Adaptive immune cells 
in amniotic fluid. Numbers of (A) total 
T cells (CD3+ cells/mL), (B) CD4+ T cells 
(CD3+ CD4+ cells/mL), (C) CD8+ T cells 
(CD3+ CD8+ cells/mL), and (D) B cells 
(CD19+ cells/mL) in amniotic fluid from 
women who underwent spontaneous 
preterm labor and birth with intra‐
amniotic inflammation or with intra‐
amniotic infection. N = 10‐16 per group. 
Midlines	=	medians,	boxes	=	interquartile	
ranges, and whiskers = minimum/
maximum	ranges
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4  | DISCUSSION
4.1 | Principal findings
Herein, we report that women with spontaneous preterm labor and 
intra‐amniotic infection had (a) a greater number of total leukocytes 
including neutrophils and monocytes/macrophages in amniotic fluid; 
(b) a higher number of total T cells and CD4+ T cells, but not CD8+ 
T cells or B cells, in amniotic fluid; and (c) increased amniotic fluid 
concentrations of IL‐6, IL‐1β, and IL‐10, compared to those with intra‐
amniotic inflammation. However, no differences in amniotic fluid 
concentrations of T‐cell cytokines and chemokines were observed 
between these two clinical conditions. Collectively, these results in‐
dicate that the cellular immune responses observed in women with 
preterm labor and intra‐amniotic infection are more severe than in 
those with intra‐amniotic inflammation and are characterized by 
an increased number of neutrophils, monocytes/macrophages, and 
CD4+ T cells.
4.2 | Amniotic fluid neutrophils in women with 
preterm labor and intra‐amniotic infection or intra‐
amniotic inflammation
It is well known that neutrophils are the most abundant immune cell 
type in the amniotic cavity of women with intra‐amniotic infection 
and/or intra‐amniotic inflammation.54,78,81,82 Yet, whether the num‐
ber of amniotic fluid neutrophils differs between intra‐amniotic in‐
flammatory processes with and without culturable microorganisms 
has not been shown until now. Herein, we showed that the number 
of amniotic fluid neutrophils is higher in women with preterm labor 
and intra‐amniotic infection than in those with intra‐amniotic inflam‐
mation without culturable microorganisms, indicating that different 
thresholds in the number of these immune cells may allow for the 
differentiation of these two clinical conditions.
In women with preterm labor and intra‐amniotic infection, as 
well as other pathogen‐mediated immune responses,83,84 neutro‐
phils participate in the main mechanisms of microbial killing: de‐
granulation,	phagocytosis,	and	neutrophil	extracellular	trap	(NET)	
formation.	For	example,	amniotic	fluid	neutrophils	can	produce	re‐
active	oxygen	species85 and release antimicrobial molecules such 
as alpha‐defensins,86‐89	myeloperoxidase,29,89,90 cathepsin G,89,91 
elastase,89,92,93 lactoferrin,94	 pentraxin‐3,95 and cathelicidin,29,89 
all of which are found in the intra‐amniotic space. Amniotic fluid 
neutrophils of fetal or maternal origin82 can also actively partici‐
pate in killing microbes invading the amniotic cavity by performing 
phagocytosis96 and forming NETs.97 Indeed, NETs are also formed 
by maternal neutrophils invading the amniotic cavity97 and chorio‐
amniotic membranes98,99 in cases with intra‐amniotic infection. In 
addition to killing microbes, amniotic fluid neutrophils can release 
pro‐inflammatory cytokines such as IL‐8, TNF‐α, MIP‐1α, MIP‐1β, 
IL‐1α, and IL‐1β into the intra‐amniotic space in cases with MIAC 
and clinical chorioamnionitis at term.54 These cytokines have been 
implicated	in	the	pathogenesis	of	preterm	labor	in	the	context	of	
intra‐amniotic infection.38,39,43,81,100‐109 Specifically, IL‐1β is a cen‐
tral mediator in the pathogenesis of preterm labor because the 
systemic110,111 and intra‐amniotic11,112‐118 administration of this 
cytokine in pregnant animals induces preterm birth. The mecha‐
nisms whereby IL‐1β induces preterm labor and birth, in the con‐
text	 of	 intra‐amniotic	 infection,	 involve	 the	 nucleotide‐binding	
oligomerization domain, leucine‐rich repeat, and pyrin domain 
containing 3 (NLRP3) inflammasome, an intracellular multiprotein 
complex	that	can	be	activated	 in	 the	fetal	membranes	by	micro‐
bial products in mice (eg, lipopolysaccharide; LPS).119 Consistently, 
women with preterm labor and acute histologic chorioamnionitis 
(a placental lesion associated with intra‐amniotic infection120‐122) 
also display inflammasome activation in the amniotic fluid34 and 
chorioamniotic membranes.123 Together, these data indicate that 
amniotic fluid neutrophils participate in both the host defense 
and inflammatory mechanisms implicated in the pathogenesis of 
preterm labor and birth in women with intra‐amniotic infection.
Women with intra‐amniotic inflammation also had neutrophils in 
their amniotic fluid; however, the numbers were lower than in those 
with intra‐amniotic infection. This finding shows that the mecha‐
nisms of inflammation occurring in women without culturable micro‐
organisms in amniotic fluid are distinct from and less severe than in 
those with intra‐amniotic infection. One possibility is that a subset 
F I G U R E  4   Pro‐inflammatory cytokines in amniotic fluid. Concentrations of (A) IL‐6 (ng/mL), (B) IL‐1β (pg/mL), (C) IL‐8 (ng/mL), and (D) 
IL‐12p70 (pg/mL) in amniotic fluid from women who underwent spontaneous preterm labor and birth with intra‐amniotic inflammation or 
with	intra‐amniotic	infection.	N	=	7‐16	per	group.	Midlines	=	medians,	boxes	=	interquartile	ranges,	and	whiskers	=	minimum/maximum	
ranges
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of women who underwent preterm labor with intra‐amniotic inflam‐
mation had elevated amniotic fluid concentrations of alarmins43 (eg, 
IL‐1α,39 HMGB1,42,124 HSP70,41 and S100B40), referred to as sterile 
intra‐amniotic inflammation.32‐34 Human studies have provided evi‐
dence that preterm labor with sterile intra‐amniotic inflammation is 
less severe than preterm labor with microbial‐induced intra‐amniotic 
inflammation.34,43,125	Indeed,	only	~50%	of	pregnant	mice	intra‐am‐
niotically injected with physiologically relevant concentrations of 
alarmins undergo preterm birth,126,127 whereas almost all of those 
injected with a microbial product (LPS) deliver preterm.128,129 The 
mechanisms whereby alarmins induced preterm labor and birth also 
involved the NLRP3 inflammasome;127,130 yet, these will be dis‐
cussed below as sterile inflammation is mainly mediated by mono‐
cytes/macrophages.131,132 Taken together, these data consistently 
show that women with preterm labor and intra‐amniotic inflamma‐
tion without culturable microorganisms had a milder intra‐amniotic 
F I G U R E  5   Type 1 and type 2 cytokines and T‐cell chemokines in amniotic fluid. Concentrations of the type 1 cytokines (A) IL‐2 (pg/mL), 
(B) IFN‐γ (pg/mL), and (C) TNF‐α (pg/mL); type 2 cytokines (D) IL‐4 (pg/mL), (E) IL‐13 (pg/mL), and (F) IL‐10 (pg/mL); and T‐cell chemokines 
(G) CXCL10 (pg/mL) and (H) CXCL11 (pg/mL) in amniotic fluid from women who underwent spontaneous preterm labor and birth with 
intra‐amniotic	inflammation	or	with	intra‐amniotic	infection.	N	=	7‐13	per	group.	Midlines	=	medians,	boxes	=	interquartile	ranges,	and	
whiskers	=	minimum/maximum	ranges
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inflammatory response, including a lower number of amniotic fluid 
neutrophils, than those with intra‐amniotic infection.
It is worth mentioning that women with preterm labor and 
intra‐amniotic inflammation may have been infected by non‐cultur‐
able microorganisms. Microorganisms such as Sneathia spp.,31,33,133 
Neisseria spp.,33,133 and Fusobacterium nucleatum31,134 have proven 
difficult to culture from amniotic fluid using traditional clinical meth‐
ods. However, whether such non‐culturable microorganisms can 
lead to a stronger intra‐amniotic inflammatory response than that 
mediated by alarmins requires further investigation.
4.3 | Amniotic fluid monocytes/macrophages 
in women with preterm labor and intra‐amniotic 
infection or intra‐amniotic inflammation
We also demonstrated that the number of monocytes/macrophages 
is increased in women with preterm labor and intra‐amniotic infection 
compared to those with intra‐amniotic inflammation. Monocytes/
macrophages are commonly found together with neutrophils in am‐
niotic fluid of women with intra‐amniotic infection and/or inflamma‐
tion.54,78 As neutrophils typically represent the dominant immune 
cell population in such women,54,78 the functions of monocytes/
macrophages	in	the	context	of	intra‐amniotic	infection	or	inflamma‐
tion have been less investigated.
Monocytes are chemo‐attracted to sites of inflammation, where 
they attain one of several different activation states depending 
on the microenvironment.135 Stimulation of innate sensors such as 
Toll‐like receptors through detection of bacterial products activates 
the	 production	 of	 reactive	 oxygen	 species	 and	 pro‐inflammatory	
cytokines such as TNF‐α, IL‐1β, and IL‐12 by monocytes,135 which 
are mediators found in amniotic fluid of women with preterm labor 
and intra‐amniotic infection.38,39,54,104‐106,136 A recent study demon‐
strated that placental macrophages can respond to microbes by 
releasing	extracellular	traps	(METs),137 suggesting that monocytes/
macrophages in the amniotic cavity may have other functions in 
addition to cytokine release. Yet, the question of whether amniotic 
fluid monocytes/macrophages are predominantly of maternal or 
fetal	origin,	especially	in	the	context	of	intra‐amniotic	infection,	re‐
mains unanswered.
Monocytes/macrophages were present, albeit in lesser numbers, 
in amniotic fluid of women with preterm labor and intra‐amniotic 
inflammation, providing further confirmation that the intra‐amni‐
otic inflammatory process is less severe in the absence of cultur‐
able microorganisms.34,43,125 In tissues, resident macrophages act as 
sentinels, orchestrating the clearance of damaged cells to maintain 
homeostasis.138 This sentinel‐like function relies, in part, on the va‐
riety of pattern recognition receptors (eg, Toll‐like receptors) and 
cytosolic	 receptors	 (eg,	 NLRP3)	 expressed	 by	 macrophages.139‐141 
Macrophages, therefore, are considered to be the first to detect 
danger signals or alarmins released by damaged cells.132 This concept 
was demonstrated by a murine study showing that sterile inflam‐
mation in response to cell death is driven by macrophages through 
the release of IL‐1α and IL‐1β.131	Moreover,	neutrophilic	influx	to	the	
site of injury was dependent on macrophage‐released cytokines, as 
deficient mice lacked such infiltration.131 These findings provide a 
model in which macrophages are the initiators of sterile inflamma‐
tion that is followed by neutrophil recruitment.132 Similarly, amniotic 
fluid monocytes/macrophages may be acting as sentinels, respond‐
ing to alarmins released upon cellular senescence of placental/fetal 
tissues142 which, in turn, will induce pro‐inflammatory immune re‐
sponses and recruit more immune cells (eg, neutrophils) into the 
amniotic cavity (ie, sterile intra‐amniotic inflammation), inducing 
preterm labor and birth. Yet, further research is required to test this 
hypothesis. In support of this concept, it has been suggested that 
fetal macrophages may initiate parturition.143,144
The molecular mechanisms of sterile inflammation in the amniotic 
cavity32‐34 are thought to involve the NLRP3 inflammasome.127,130 
Inflammasome	 complexes	 assemble	 to	 provide	 a	 scaffold	 for	 ac‐
tivation of caspase‐1,145‐163 which, in turn, cleaves pro‐IL‐1β and 
pro‐IL‐18 into their mature and active forms.164‐171 Inflammasome 
activation can result in an inflammatory type of cell death, referred 
to as pyroptosis,172‐175 in which the molecule gasdermin D forms 
pores in the host cell membrane, 173,176‐179 allowing for the release 
of cytosolic proteins such as IL‐1β.166,169 Pyroptosis was originally 
described in macrophages,172,173,180 and we recently demonstrated 
that the effector molecule of pyroptosis, gasdermin D, is present in 
amniotic fluid of women with preterm labor and sterile intra‐amni‐
otic inflammation.125 Herein, we propose that amniotic fluid mono‐
cytes/macrophages undergo inflammasome‐mediated pyroptosis, 
a potential mechanism for sterile intra‐amniotic inflammation in 
women with preterm labor.
Collectively, these findings indicate that amniotic fluid mono‐
cytes/macrophages play different roles in subsets of women with 
preterm labor: While cytokine release and MET formation are cen‐
tral to intra‐amniotic infection, inflammasome‐mediated pyroptosis 
occurs in the setting of sterile intra‐amniotic inflammation.
4.4 | Amniotic fluid CD4+ T cells in women with 
preterm labor and intra‐amniotic infection or intra‐
amniotic inflammation
In the current study, we found that CD4+ T cells, but not CD8+ T 
cells, are increased in women with preterm labor and intra‐amni‐
otic infection compared to those with intra‐amniotic inflammation. 
This is consistent with our previous report showing that T cells are 
one of the dominant immune cell populations present in the am‐
niotic fluid of women in preterm gestation.55 These adaptive cells 
are likely derived from the fetus, as amniotic fluid neutrophils in 
preterm gestation are predominantly of fetal origin; 82 however, 
their origin has yet to be elucidated. Our findings are in line with 
previous reports showing that fetal immune activation occurs in 
preterm labor181,182 and that a population of central memory CD4+ 
T cells is increased in the cord blood of preterm neonates born to 
women with preterm labor.183 Such a fetal T‐cell response could be 
initiated by in utero	exposure	to	pathogens184‐186 and/or maternal 
antigens.183,187 The mechanisms whereby fetal T cells could initiate 
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preterm parturition involve the secretion of pro‐inflammatory me‐
diators, such as IFN‐γ and TNF‐α, and the activation of myometrial 
contractility.183 Whether fetal T‐cell activation is implicated in the 
mechanisms leading to preterm labor and birth in the absence of 
intra‐amniotic infection/inflammation is still unknown.
5  | CONCLUSION
In the current study, we report that women with spontaneous pre‐
term labor and intra‐amniotic infection had increased numbers of 
amniotic fluid neutrophils, monocytes/macrophages, and CD4+ T 
cells compared to those with intra‐amniotic inflammation. Such 
cellular immune responses were accompanied by elevated am‐
niotic fluid concentrations of IL‐6, IL‐1β, and IL‐10. These results 
provide evidence that the cellular immune responses observed in 
women with preterm labor and intra‐amniotic infection are more 
severe than in those with intra‐amniotic inflammation, and that 
neutrophils, monocytes/macrophages, and CD4+ T cells are the 
main immune cells responding to microorganisms invading the am‐
niotic cavity.
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